The N-terminal calponin homology (CH) domain of Vav guanine nucleotide exchange factor is thought to serve a regulatory role in the autoinhibition, however, its precise function is not entirely clear. We found that the adaptor molecule APS could bind the CH domain of Vav3, a member of the vav proto-oncogene family. The binding of Vav3 and APS was apparently stabilized by the tyrosine phosphorylation of Vav3 by Lck, and the association of APS with Vav3 in turn enhanced the Lck-mediated phosphorylation of Vav3. Focus formation assays demonstrated that APS could increase the transforming activity of proto-Vav3. Further analyses revealed that the Vav3 CH domain could bind the pleckstrin homology (PH) domain of APS and that this binding was indispensable to enhance the transforming activity of Vav3. We present here a novel stimulatory mechanism of Vav3 in which APS directly relieves the autoinhibitory CH domain and furthermore enhances its tyrosine phosphorylation by Lck.
Introduction
The small molecular weight GTPases represented by Rac, Rho and Cdc42 are implicated in a variety of biological activities including the regulation of cellular motility, morphology, cellular polarity, malignant transformation and tumor metastasis (Clark et al., 2000; Hall, 1998; van Aelst and D'Souza-Schorey, 1997) . Although many studies have clearly demonstrated that the guanine nucleotide exchange factors (GEFs) carrying the Dbl homology (DH) domain and pleckstrin homology (PH) domain activate Rho family small guanine nucleotide-binding proteins from GDPto GTP-bound form (Cerione and Zheng, 1996; Whitehead et al., 1997) , the mechanisms which control the GEF activities still remain to be elucidated. Vav is one of the well-studied GEF (Bustelo, 2000; Katzav et al., 1989) , which is composed of an N-terminal calponin homology (CH) domain followed by an acidic (Ac) domain, the DH and PH domains, a zinc-finger domain and a set of SH3-SH2-SH3 domains (SH, src homology) at the C-terminus. After the isolation of Vav (Vav1), two related proteins Vav2 and Vav3 carrying the same array of domains have been identified (Abe et al., 2000; Movilla and Bustelo, 1999; Schuebel et al., 1998; Zeng et al., 2000) . Genetic loss-of-function of Vav1 and Vav2 have revealed their crucial roles in the T-cell receptor and B-cell receptormediated intracellular calcium mobilization (Doody et al., 2001; Tedford et al., 2001) . Vav3 displays predominant expression in spleen and peripheral leukocytes, and recent evidences suggest that it also participates in the downstream signaling of T-cell and B-cell receptor (Inabe et al., 2002; Moores et al., 2000; Movilla and Bustelo, 1999; Zeng et al., 2000) .
The guanine nucleotide exchange activity of Vav1 for the small-G protein Rac1 is stimulated by phosphorylation of tyrosine174 in the Ac region of Vav1 by Lck . Analysis using NMR spectroscopy demonstrated that the C-terminus of the Ac region containing Tyr174 could associate with the GTPase-interacting region of the Vav1 DH domain, and the phosphorylation of Tyr174 weakens this interaction (Aghazadeh et al., 2000) . The activity of Vav1 is also controlled by binding with phosphatidylinositol-4,5-bisphosphate (PI-4,5-P 2 ) and phosphatidylinositol-3,4,5-triphosphate (PI-3,4,5-P 3 ) via the PH domain (Das et al., 2000; Han et al., 1998) . The Vav1 binding with PI-3,4,5-P 3 , but not with PI-4,5-P 2 suppresses the inhibitory intramolecular interaction of the PH and DH domains. The altered folding of the DH-PH array by PI-3,4,5-P 3 is thought to allow further phosphorylation of Tyr174 by Lck and this modification further inhibits the autoinhibitory interaction between the DH and PH domains to enhance the GEF activity.
The CH domain of Vav1 has been thought to serve an autoinhibitory role in transforming activity because the originally isolated onco-Vav1 which carries an Nterminal deletion of 65 residues in this domain has the prominent focus forming activity on NIH3T3 cells (Katzav et al., 1991) . The CH domain is a conserved motif found in several signal mediator proteins including IQGAP, yeast Cdc24 as well as Vav and also in actin-binding regions of some cytoskeletal proteins (Adams et al., 1992; Castresana and Saraste, 1995; Stradal et al., 1998) . While the CH domain of Vav1 has been predicted to be involved in the association with actin (Castresana and Saraste, 1995) , some evidence suggest it does not participate in actinbinding Stradal et al., 1998) . Although no direct evidence has been produced, the entire CH and Ac domains of Vav1 are thought to bind the intramolecular C-terminal portion to impair the association with membrane-containing cellular fractions (Abe et al., 1999) .
To address the function of the CH domain in Vavfamily proteins, we attempted to identify proteins which bind the CH domain of Vav3, and as a result APS was isolated. APS is an adaptor protein comprising of a proline rich motif, a PH domain and an SH2 domain, which is phosphorylated on tyrosine residues by B-cell receptor stimulus and associates with several SH2 domain-carrying molecules such as Cbl, Grb2, and Shc (Yokouchi et al., 1997) . Other adaptor proteins Lnk and SH2-B have amino acid sequence similarities with APS and they consist of a gene family (Osborne et al., 1995; Takaki et al., 2000) . We found that tyrosine phosphorylation of Vav3 by Lck increased the interaction of APS with Vav3, and the association of APS with Vav3 sequentially enhanced the tyrosine phosphorylation of Vav3. The focus formation assay revealed that APS promoted the transforming activity of proto-Vav3. These observations suggest that APS is a positive regulator of Vav3, which suppresses the autoinhibitory effect of the CH domain.
Results

APS binds the CH domain of Vav3
In our attempt to isolate interacting proteins with vascular endothelial growth factor (VEGF) receptor-2, we have isolated the vav3 gene although its role in VEGF signaling is still under investigation. Unlike Vav1, Vav3 showed a lower level of tyrosine phosphorylation in hematopoietic cell lines (data not shown). From this we assumed that Vav3 has other regulatory mechanism besides tyrosine phosphorylation and thus examined the role of the autoinhibitory CH domain. In order to address the regulatory function of the Vav3 CH domain, we performed yeast two-hybrid screening and identified APS as a protein which binds to the CH domain (see Materials and methods).
To verify complex formation of Vav3 with APS in intact mammalian cells, we exogenously expressed Vav3 and FLAG-tagged APS (FLAG-APS) in 293T human embryonic kidney cells which do not contain endogenous Vav3 or Vav1 protein. As shown in Figure  1a , Vav3 was detected in anti-FLAG immunoprecipitated APS complexes. In a parallel experiment using Vav1, we found that APS also binds Vav1 (Figure 1b) . To investigate whether the other members of the Lnk family bind Vav3 or Vav1, FLAG-tagged Lnk was cotransfected into cells and immunoprecipitated using the anti-FLAG antibody. Lnk only weakly coprecipitated with Vav1 (Figure 1b) . Since Src related kinases play crucial roles in Vavmediated physiological signaling of hematopoietic cells (Deckert et al., 1996; Katzav et al., 1994) , we analysed the effect of Lck-mediated phosphorylation of Vav1 or Vav3 on their binding properties. The amounts of Vav1 or Vav3 in anti-FLAG immuno-complexes were increased 3 -4-fold in the presence of Lck Y505F, the constitutive active form of Lck, indicating that the tyrosine phosphorylated Vav proteins could efficiently associate with APS or Lnk protein (Figure 1a,b) .
APS augments the activity of Vav3 and Vav1 in vivo
Co-expression of Vav1 and its activator Lck synergistically enhances the cellular transforming activity, most likely via the activation of its target small G proteins (Han et al., 1997) . To evaluate the biological effect of APS-binding to the Vav3 CH domain, we tested whether Lnk-family adaptor proteins could enhance the transforming activity of Vav3. As Zheng et al. (2000) reported that onco-vav3 expression via the EF1a promoter could transform NIH3T3 cells to induce foci, we used the same promoter to evaluate the potential transforming activity of vav3. We transfected the wildtype vav3 gene into NIH3T3 cells either alone or in combination with FLAG-APS and the transformed foci were scored 15 days after transfection ( Figure 2 ). While FLAG-APS cDNA did not transform NIH3T3 cells, the full-length vav3 cDNA induced a low number of transformed foci. Co-transfection of FLAG-APS with vav3 increased the number of foci about fourfold suggesting that APS cooperates with Vav3 to transform NIH3T3 cells. Expression of the authentic APS gene without the FLAG tag led to the same efficiency of focus formation (data not shown). APS could not enhance the focus-forming ability of proto-Dbl (data not shown), thus the cooperative effect of APS appears to be specific for Vav3. Because the CH domain of Vav family proteins serve as negative regulatory element for transforming ability, we suggest that the stimulatory effect of APS is due to a neutralization of the autoinhibitory function of the CH domain.
Since APS binds Vav1 as well as Vav3 (Figure 1b ), a similar assay was performed using vav1. In contrast to vav3, the addition of FLAG-APS did not increase the number of transformed foci induced by the full-length vav1. However, a significant number of microfoci were observed when we co-expressed vav1 and APS ( Figure  2 , bottom panel), implying a weak but stimulatory effect of APS on Vav1 signaling. We further tested the synergistic effect of vav1 and FLAG-tagged Lnk on NIH3T3 cells, since Vav1 binds Lnk ( Figure 1b ). Unlike APS, Lnk failed to enhance the transforming activity of vav1, presumably because the binding affinity of Lnk with Vav1 is considerably weaker than that of APS as shown in Figure 1b .
To examine whether the activation of vav3 by APS causes the changes in cell morphology, we transiently introduced vav3 and APS to NIH3T3 cells and stained actin with rhodamine-conjugated phalloidin as described in Materials and methods. The overexpression of vav3 in NIH3T3 cells has been reported to induce membrane ruffling and microspike formation (Zeng et al., 2000) . In our experimental condition a proportion of vav3-transfected cells demonstrated membrane ruffles (10%), however, the ruffles were significantly smaller than those induced by constitutively active Rac1 (Rac1Q61L). When we co-expressed vav3 and APS, a significant fraction (38%) of transfected NIH3T3 cells displayed the refringent rounded cell shapes with actin bundles of perimembrane area ( Figure 3 ) and small membrane ruffles. On the other hand, the transfection with APS or hrGFP alone did not enhance any morphological changes. This result suggests that APS could enhance the activity of Vav3 and its downstream Rho family GTPases, which induce the actin cytoskeletal reorganization.
APS enhances the tyrosine phosphorylation of Vav3 by Lck
The phosphorylation of tyrosine residues by Lck is a crucial step for the activation of Vav family proteins . Since APS enhanced the transforming activity of Vav3, we investigated whether this stimulatory effect is mediated by an increase of tyrosine phosphorylation in Vav3. In a transient express system using 293T cells, tyrosine phosphorylation of Vav3 was not observed in the presence of APS (Figure 4a , lanes 1 and 2), indicating that the stimulatory effect of APS on Vav3 is not due to an increase in tyrosine phosphorylation of Vav3. When we co-expressed an active form of Lck (LckY505F) in the cells, the tyrosine phosphorylation of Vav3 was clearly observed and this phosphorylation was strongly enhanced in the presence of APS (Figure 4b , lanes 2 and 3). These results suggest that while APS directly augments the transforming activity of Vav3 independent of tyrosine phosphorylation, it could also promote the phosphorylation by Lck to further activate Vav3. We performed a similar experiment with Vav1, however, unlike Vav3 we could not observe any increase in phospho-tyrosine residues by APS or Lnk (Figure 4d ).
Vav3 CH domain interacts with the PH domain of APS
Since APS protein contains several defined sequence motifs, we determined the motif responsible for the interaction with the CH domain of Vav3. Several portions of APS were cloned into yeast two-hybrid expression vectors and their interaction with the Vav3 CH domain fused to the Gal4 DNA binding domain was examined by monitoring the growth of yeast transformants on medium lacking His (Figure 5a ). The fragment containing the full-length of the APS PH domain (fragment #5) efficiently bound to the CH, whereas the fragment lacking the N-terminal b1 sheet of the PH and its 21 proximal residues (fragment #6) failed to interact with the Vav3 CH (Figure 5a) . A deletion of the C-terminal half of the PH domain also impaired the interaction (fragment #7). Taken together these results suggest that the PH domain of APS is necessary and sufficient for binding with the Vav3 CH domain.
To confirm the results obtained in the two-hybrid analysis, we carried out an in vitro solution binding assay. For this purpose, the PH domain of APS was purified as a GST fusion protein (GST-APS-PH), immobilized on beads and evaluated the capacity to bind the CH polypeptide of Vav3 produced by an in vitro coupled transcription and translation system. Consistent with the two-hybrid assay, the GST-APS-PH was found to associate with the Vav3 CH, while the mutant APS-PH carrying an N-terminal deletion of this domain (GST-APS-PHDN) did not bind the CH (Figure 5b) .
To further investigate the role of the APS PH domain, we evaluated the ability of mutant APS to 
Discussion
Deletion of the N-terminal CH domain of Vav1 and
Vav3 was shown to result in a remarkable stimulation of transforming activity (Katzav et al., 1991; Zeng et al., 2000) , however, its role, and in particular the precise mechanism of the activation remained unclear. The Polycomb gene family product, Enx-1 has been identified as a protein which binds to the CH domain of Vav1 (Hobert et al., 1996) , however, its role in the regulation of Vav1 is still unknown. Therefore we attempted to identify proteins binding to the CH domain of Vav3. Although one presumes to identify proteins promoting the negative regulatory function of the CH domain, the adaptor molecule APS we identified showed the opposite features. In our analyses APS increased the focus formation ability of vav3 and cooperated with Vav3 to enhance actin reorganization in fibroblast cells. The tyrosine phosphorylation by Lck, which is a crucial controlling step for Vav-family proteins strengthened the association of APS and Vav3, and this association sequentially enhanced the tyrosine phosphorylation of Vav3. These results obviously suggest that the binding of APS to the Vav3 CH domain stimulates the Vav3-signaling.
The N-terminal deletion of many GEFs including Dbl, Tiam1, Ect2, Ost and Net1 as well as Vav proteins confers constitutive activation, although these sequences do not share significant homology (Alberts and Treisman, 1998; Habets et al., 1994; Horii et al., 1994; Miki et al., 1993; Ron et al., 1989) . Recently the N-terminal autoinhibitory domain of proto-Dbl was shown to bind the intramolecular PH domain and thus regulate the intracellular distribution and GEF activity (Bi et al., 2001) . These results suggest that the Nterminal regions of GEFs may all play a negative regulatory role in a similar manner. On the other hand several lines of evidence suggest that activators could bind to this domain. For example, the tumor suppressor gene product adenomatous polyposis coli (APC) binds to the autoinhibitory N-terminal region of Rac-GEF Asef and activates the GEF activity (Kawasaki et al., 2000) . Another example is p115 RhoGEF in which the negative regulatory RGS domain interacts with G 13 a to enhance the GEF activity and membrane translocation (Bhattacharyya and Wedegaertner, 2000; Hart et al., 1998) .
The employment of APS in controlling the activity of Vav3 resembles that of other GEF regulators, however, the precise mechanism of the regulation is still uncertain and several mechanisms are possible. First the co-expression of APS may enhance the protein stability by inhibiting the SOCS-1-or Cblmediated ubiquitin-dependent degradation and thus increasing the expression of Vav proteins De Sepulveda et al., 2000) . Although we do not have any direct evidence to rule out this possibility, in our transient expression system APS did not substantially increased the amount of Vav3 or Vav1.
A second possibility is that APS may augment the GEF activity of Vav3 by inducing a conformational change and increase the efficiency of the DH domain associations with its substrates. The autoinhibitory effect of the CH domain in GEF activity is still open to question because proto-Vav1 and onco-Vav1 have been reported to have comparable GEF activity and moreover, the putative oncogenic form of Vav2 lacking Nterminal 67 amino acids did not show any increase of transforming activity Schuebel et al., 1996) . On the other hand, by deleting the 144 amino acids which contain the entire CH domain and the N-terminus of the Ac region, Vav3 showed a significant increase in binding affinity to RhoA (Movilla and Bustelo, 1999) . We have attempted to evaluate the GEF activity using proto-Vav3 and APS generated in baculovirus system, however, so far we have not been able to reproducibly measure the effect of the APS association with Vav3. The possibility of direct activation of the DH domain by APS therefore needs to be examined further. It is also important to determine whether the CH domain can actually bind the intramolecular DH domain and block the GEF activity.
A third model is that APS directs the translocation of Vav3 to the membrane, since the N-terminal CH and Ac domains inhibit the recruitment of Vav1 to the membrane and cytoskeletal fraction (Abe et al., 1999) . Figure 6 The PH domain of APS is essential for the cooperativity with Vav3. NIH3T3 cells were co-transfected with plasmids containing vav3 (1 mg) alone or in combination with 1 mg of vectors encoding either the FLAG tagged APS (APS) or APS lacking the N-terminus region of the PH domain (APS-PHDN) and the foci of transformed cells scored 15 days after transfection. The expression of FLAG tagged APS protein constructs was confirmed with the anti-FLAG antibody by the Western blot analysis using the total lysate of cells 48 h after transfection (right panel). The picture shows the crystal violet staining of the tissue culture plates from a representative assay. Values in bottom panel represent the mean and standard deviation of three independent experiments performed in duplicate Our preliminary membrane fractionation experiment revealed that the association of APS and Vav3 prompted the mobilization of Vav3 to the fraction containing the membrane and cytoskeleton (data not shown). Thus APS appears to participate in the membrane recruitment of Vav family proteins by dictating the CH domain, and allow them to efficiently associate with its regulators such as PI-3,4,5-P 3 or Src related kinases and with its substrates, the Rho-family GTPases.
Finally, APS may regulate the Vav3 by enhancing Lck-mediated tyrosine phosphorylation. The phosphorylation by Lck in the acidic domain plays a pivotal role in regulating the GEF activity of Vav proteins in vitro , and several tyrosine kinases including Syk and ZAP-70 are involved in tyrosine phosphorylation of Vav1 in vivo (Deckert et al., 1996; Katzav et al., 1991) . As coexpression of APS strongly induced the phosphorylation by Lck, this stimulatory effect may also explain the positive regulation of APS. However, the activation of Vav3 by Lck-mediated phosphorylation is supposed to be an indirect effect of APS, because even in the absence of active Lck, APS apparently increased the transforming activity of Vav3 without detectable tyrosine phosphorylation. One plausible explanation is that the binding of APS to Vav3 CH domain causes the conformational change that exposes the tyrosine residues in the adjacent acidic domain for Lck-mediated phosphorylation. The tyrosine phosphorylation releases the autoinhibitory acidic domain (Aghazadeh et al., 2000) , and may result in the CH domain being more accessible for binding to APS.
The activation of Vav3 by APS may participate in the B cell receptor (BCR) signaling, since both Vav3 and APS are tyrosine phosphorylated by BCR stimulation (Yokouchi et al., 1997; Zeng et al., 2000) and tyrosine phosphorylation strengthened the complex formation between Vav3 and APS. The augment of Vav3 activity by APS could result in the activation of Rho-family GTPases and subsequent stimulation of PIP5 kinase. Our study further implies that APS is a distinctive regulator of Vav3 in B-cell and T-cell receptor signaling, because APS is expressed in spleen but not in thymus (Iseki et al., 2000; Yokouchi et al., 1997) . While evidences showed that Vav1 indeed participates in B-cell receptor signaling (Doody et al., 2001; Tedford et al., 2001 ), APS does not appear to effectively regulate Vav1 since APS only weakly augmented the focus formation ability of Vav1. It might be possible that intracellular signaling mediated by APS strengthen the activity of Vav3 but not Vav1, resulting in the specific physiological response. While our data suggest a positive role for APS in cellular signaling, the physiological consequence of the association of Vav3 and APS still remains to be seen since other results showed that APS inhibited the tyrosine phosphorylation signaling by associating with Cbl Yokouchi et al., 1999) .
Materials and methods
Yeast two-hybrid screen
The N-terminal domain of Vav3 (residues 1 to 125) was cloned into the Gal4 DNA binding domain fusion protein vector pAS1-CYH2 (Clontech). This bait plasmid was cotransformed with a human lymphocyte cDNA library (Clontech) constructed on pACT2 into the CG-1945 yeast strain and 1.5610 6 transformants were screened. We isolated 35 plasmids for putative interactors with CH domain and all of them turned out to encode the APS gene. For the determination of binding domains in the two-hybrid assay, the respective APS fragments were obtained by PCR, and cloned into the Gal4 Activation domain fusion vector pACT2, sequentially transformed into the CG-1945 strain, and examined for reporter gene activity. In this study the residue 193 of APS was determined as the N-terminal end of the PH domain by aligning the primary sequence with that of other PH domains.
Expression in 293T cells and immunoprecipitation
293T human kidney epithelial cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 2 mM glutamine and 10% fetal bovine serum. Transient DNA transfections were performed by the calcium phosphate precipitation method. A 5 mg aliquot of each expression vector for the cDNAs was used to transfect 293T cells (5610 6 cells/10 cm plate). Cognate empty vectors were used to adjust the amount of DNA in the precipitation. The total cellular lysate of 293T cells was obtained 48 -60 h after transfection by incubation with HNTG buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1.5 mM MgCl 2 , 50 mM NaF, 10 mM Na 4 P 2 O 7 , 5 mM EDTA, 1 mM Na 3 VO 4 , 1 mM PMSF, 2% Trasylol) and subsequent centrifugation. Immunoprecipitation was carried out by incubating the precleared lysate with either the M2 (anti-FLAG), anti-Vav1 or anti-Vav3 antibodies complexed with proteinA-or proteinG-sepharose for 3 h in 48C followed by five washes with HNTG buffer.
Focus formation assay
Focus formation assay was performed essentially as described by Clark et al. (1995) . NIH3T3 cells were propagated in DMEM supplemented with 10% calf serum (Gibco BRL). Transfection of fibroblasts (5610 5 cells/6 cm plate) was performed by the calcium phosphate precipitation method using 20 mg of calf thymus DNA (Roche). From 24 h after transfection, the cells were fed with DMEM 5% calf serum and cultured in the same medium for 15 days. After this period the cells were fixed with formaldehyde and stained with crystal violet (0.5%) to count the foci of morphologically transformed cells.
Actin staining
NIH3T3 cells were grown on 8-well collagen-I coated chamber slides (BD Falcon) at 3610 3 /well. Transient cotransfection was performed using Effectene (QIAGEN) with the combination of 10 ng of phrGFP-C (Stratagene), vav3-expression plasmid (40 ng), His 6 -tagged APS-expression plasmid (40 ng) or cognate empty vectors. Twenty-four hours after transfection cells were serum starved for 16 h to lower the background. Cells were washed twice with Hanks balanced salt solution (Gibco BRL), fixed in 3.7% paraformaldehyde for 30 min and permeabilized in 0.1% Triton X-100 for 20 min at room temperature. After three times rinsing with PBS, the slides were incubated with rhodamine-labeled phalloidin (Molecular Probe) for 30 min followed by three washes with PBS.
In vitro binding assay GST fusion proteins of the PH (residues 171 to 340), or PHDN (residues 204 to 340) domain of APS were amplified by PCR and subcloned into pGEX-5X-3 (Amersham Pharmacia). The fused proteins were freshly prepared from Escherichia coli by affinity chromatography with glutathionesepharose beads. Vav3 CH domain (residues 1 to 125) was produced by coupled transcription/translation using the reticulocyte lysate system (Promega) in the presence of [ 35 S]methionine. A 5 ml aliquot of translated mixture was added to 2 mg of GST-fused proteins in 0.5 ml of HNTG buffer and incubated at 48C for 1 h before being washed four times with HNTG buffer. Bound proteins were subjected to SDS-polyacrylamide gel electrophoresis and subsequent fixation and fluorography. In a lane for the input 4% of reaction mixture was loaded. The band for the CH domain of Vav3 was quantitated using a Fujix Image Analyzer.
Molecular constructs and antibodies
Vav3 cDNA fragment was isolated from human placenta cDNA library (Clontech) in our yeast two-hybrid screening for proteins interacting with the intracellular domain of VEGF receptor-2. The full-length of vav3 cDNA was obtained from the lgt10 cDNA phage library of human leukocyte (Clontech) by a standard library screening protocol. The full-length cDNA of vav1 was isolated from the same library using an RT -PCR-amplified cDNA fragment of vav1 obtained from the total RNA of a Jurkat cell line as a probe. Our isolated APS cDNA contained a 46 nucleotide longer 5' untranslated region and an in-frame methionine codon was found adjacent to the BamHI site corresponding to the 5' end of the reported sequence (Yokouchi et al., 1997) . FLAG tagged APS was constructed by inserting the appropriate synthesized DNA encoding the Kozak sequence and FLAG tag into this BamHI site and expressed under Elongation Factor 1a (EF1a) promoter. His 6 tagged APS was generated by inserting the Kozak sequence and His 6 GS to the start codon of APS using PCR technique and expressed under CMV promoter. Lnk cDNA was isolated from total RNA of Jurkat cells using a standard RT -PCR technique. FLAG tagged Lnk was obtained by inserting the appropriate linker encoding Kozak and FLAG into an NcoI site generated at the start codon of Lnk. To construct the PHDN-APS, the SfiI-MscI fragment of APS was replaced with a PCR-generated DNA fragment in which residues 182 to 205 were replaced by single leucine residue. For transient expression and focus formation assays the constructs of Vav proteins and Lnk-family proteins were expressed under the EF1a promoter.
Antibody directed to Vav3 was raised by immunizing rabbits with synthesized Vav3 peptide (residues 768 to 787) coupled to keyhole limpet hemocyanin followed by affinity column purification using the peptide. Antibodies against Vav1, Lck, GST, His 6 and phospho-tyrosine (4G10) were purchased from Upstate Biotechnology, M2 antibody for FLAG was from Sigma Aldrich. The plasmid expressing the constitutively active form of Lck (LckY505F) was a generous gift from Drs T Tezuka and T Yamamoto.
